|
1
|
Zhu AX: Molecularly targeted therapy for
advanced hepatocellular carcinoma in 2012: current status and
future perspectives. Semin Oncol. 39:493–502. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
3
|
Padma S, Martinie JB and Iannitti DA:
Liver tumor ablation: percutaneous and open approaches. J Surg
Oncol. 100:619–634. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ichida T, Van Thiel DH and Hassanein T:
The medical management of hepatocellular carcinoma (HCC) in Japan:
a review with implications for HCC seen in the west.
Hepatogastroenterology. 43:1575–1583. 1996.PubMed/NCBI
|
|
5
|
Bruix J and Sherman M; Practice Guidelines
Committee, American Association for the Study of Liver Diseases.
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar
|
|
6
|
Llovet JM, Real MI, Montaña X, et al:
Arterial embolisation or chemoembolisation versus symptomatic
treatment in patients with unresectable hepatocellular carcinoma: a
randomised controlled trial. Lancet. 359:1734–1739. 2002.
View Article : Google Scholar
|
|
7
|
Choo CY, Sulong NY, Man F and Wong TW:
Vitexin and isovitexin from the leaves of Ficus deltoidea
with in-vivo α-glucosidase inhibition. J Ethnopharmacol.
142:776–781. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Knipping K, Garssen J and van't Land B: An
evaluation of the inhibitory effects against rotavirus infection of
edible plant extracts. Virol J. 9:1372012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sahreen S, Khan MR and Khan RA:
Hepatoprotective effects of methanol extract of Carissa
opaca leaves on CCl4-induced damage in rat. BMC
Complement Altern Med. 11:482011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee CY, Chien YS, Chiu TH, et al:
Apoptosis triggered by vitexin in U937 human leukemia cells via a
mitochondrial signaling pathway. Oncol Rep. 28:1883–1888.
2012.PubMed/NCBI
|
|
11
|
Papi A, Farabegoli F, Iori R, et al:
Vitexin-2-O-xyloside, raphasatin and (−)-epigallocatechin-3-gallate
synergistically affect cell growth and apoptosis of colon cancer
cells. Food Chem. 138:1521–1530. 2013.PubMed/NCBI
|
|
12
|
Xin H, Kong Y, Wang Y, et al: Lignans
extracted from Vitex negundo possess cytotoxic activity by
G2/M phase cell cycle arrest and apoptosis induction.
Phytomedicine. 20:640–647. 2013.
|
|
13
|
Zhou Y, Liu YE, Cao J, et al: Vitexins,
nature-derived lignan compounds, induce apoptosis and suppress
tumor growth. Clin Cancer Res. 15:5161–5169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan Z and Zhang Y, Deng J, Zeng G and
Zhang Y: Purified vitexin compound 1 suppresses tumor growth and
induces cell apoptosis in a mouse model of human choriocarcinoma.
Int J Gynecol Cancer. 22:360–366. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McCubrey JA, Steelman LS, Chappell WH, et
al: Mutations and deregulation of Ras/Raf/MEK/ERK and
PI3K/PTEN/Akt/mTOR cascades which alter therapy response.
Oncotarget. 3:954–987. 2012.PubMed/NCBI
|
|
16
|
Muntané J, De la Rosa AJ, Docobo F,
Garcia-Carbonero R and Padillo FJ: Targeting tyrosine kinase
receptors in hepatocellular carcinoma. Curr Cancer Drug Targets.
13:300–312. 2013.PubMed/NCBI
|
|
17
|
Cervello M, McCubrey JA, Cusimano A,
Lampiasi N, Azzolina A and Montalto G: Targeted therapy for
hepatocellular carcinoma: novel agents on the horizon. Oncotarget.
3:236–260. 2012.PubMed/NCBI
|
|
18
|
Cai C, Teng L, Vu D, et al: The heme
oxygenase 1 inducer (CoPP) protects human cardiac stem cells
against apoptosis through activation of the extracellular
signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine
release. J Biol Chem. 287:33720–33732. 2012. View Article : Google Scholar
|
|
19
|
Xu X, Fan Z, Kang L, et al: Hepatitis B
virus X protein represses miRNA-148a to enhance tumorigenesis. J
Clin Invest. 123:630–645. 2013.PubMed/NCBI
|
|
20
|
Yang JY and Hung MC: Deciphering the role
of forkhead transcription factors in cancer therapy. Curr Drug
Targets. 12:1284–1290. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arden KC: Multiple roles of FOXO
transcription factors in mammalian cells point to multiple roles in
cancer. Exp Gerontol. 41:709–717. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hu MC, Lee DF, Xia W, et al: IκB kinase
promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell.
117:225–237. 2004.
|
|
23
|
Potente M, Urbich C, Sasaki K, et al:
Involvement of Foxo transcription factors in angiogenesis and
postnatal neovascularization. J Clin Invest. 115:2382–2392. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brunet A, Bonni A, Zigmond MJ, et al: Akt
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang JY, Zong CS, Xia W, et al: ERK
promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated
degradation. Nat Cell Biol. 10:138–148. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim SH, Jeong JH, Kim TI, Kim SW and Bull
DA: VEGF siRNA delivery system using arginine-grafted bioreducible
poly(disulfide amine). Mol Pharm. 6:718–726. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Du J, Gao S, Luo J, et al: Effective
inhibition of foot-and-mouth disease virus (FMDV) replication in
vitro by vector-delivered microRNAs targeting the 3D gene. Virol J.
8:2922011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guerrero AD, Schmitz I, Chen M and Wang J:
Promotion of caspase activation by caspase-9-mediated feedback
amplification of mitochondrial damage. J Clin Cell Immunol. 3:pii:
1000126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ranjan K, Surolia A and Pathak C:
Apoptotic potential of Fas-associated death domain on regulation of
cell death regulatory protein cFLIP and death receptor mediated
apoptosis in HEK 293T cells. J Cell Commun Signal. 6:155–168. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamasaki Y, Yamasaki M, Tachibana H and
Yamada K: Important role of β1-integrin in fucoidan-induced
apoptosis via caspase-8 activation. Biosci Biotechnol Biochem.
76:1163–1168. 2012.
|
|
31
|
Kornblau SM, Singh N, Qiu Y, Chen W, Zhang
N and Coombes KR: Highly phosphorylated FOXO3A is an adverse
prognostic factor in acute myeloid leukemia. Clin Cancer Res.
16:1865–1874. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vadlakonda L, Pasupuleti M and Pallu R:
Role of PI3K-AKT-mTOR and Wnt signaling pathways in transition of
G1-S phase of cell cycle in cancer cells. Front Oncol. 3:852013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pardo PS, Lopez MA and Boriek AM: FOXO
transcription factors are mechanosensitive and their regulation is
altered with aging in the respiratory pump. Am J Physiol Cell
Physiol. 294:C1056–C1066. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nho RS, Hergert P, Kahm J, Jessurun J and
Henke C: Pathological alteration of FoxO3a activity promotes
idiopathic pulmonary fibrosis fibroblast proliferation on type I
collagen matrix. Am J Pathol. 179:2420–2430. 2011. View Article : Google Scholar
|
|
35
|
Wang X, Chen WR and Xing D: A pathway from
JNK through decreased ERK and Akt activities for FOXO3a nuclear
translocation in response to UV irradiation. J Cell Physiol.
227:1168–1178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xie C, Song LB, Wu JH, et al: Upregulator
of cell proliferation predicts poor prognosis in hepatocellular
carcinoma and contributes to hepatocarcinogenesis by downregulating
FOXO3a. PLoS One. 7:e406072012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ghosh AP, Klocke BJ, Ballestas ME and Roth
KA: CHOP potentially co-operates with FOXO3a in neuronal cells to
regulate PUMA and BIM expression in response to ER stress. PLoS
One. 7:e395862012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao XC, Cao XC, Liu F, Quan MF, Ren KQ
and Cao JG: Regulation of the FOXO3a/Bim signaling pathway by
5,7-dihydroxy-8-nitrochrysin in MDA-MB-453 breast cancer cells.
Oncol Lett. 5:929–934. 2013.PubMed/NCBI
|
|
39
|
Cunha DA, Igoillo-Esteve M, Gurzov EN, et
al: Death protein 5 and p53-upregulated modulator of apoptosis
mediate the endoplasmic reticulum stress-mitochondrial dialog
triggering lipotoxic rodent and human β-cell apoptosis. Diabetes.
61:2763–2775. 2012.PubMed/NCBI
|
|
40
|
He L, Yang X, Cao X, Liu F, Quan M and Cao
J: Casticin induces growth suppression and cell cycle arrest
through activation of FOXO3a in hepatocellular carcinoma. Oncol
Rep. 29:103–108. 2013.PubMed/NCBI
|
|
41
|
Chen Q, Ganapathy S, Singh KP, Shankar S
and Srivastava RK: Resveratrol induces growth arrest and apoptosis
through activation of FOXO transcription factors in prostate cancer
cells. PLoS One. 5:e152882010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Boreddy SR, Pramanik KC and Srivastava SK:
Pancreatic tumor suppression by benzyl isothiocyanate is associated
with inhibition of PI3K/AKT/FOXO pathway. Clin Cancer Res.
17:1784–1795. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Roy SK, Srivastava RK and Shankar S:
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of
FOXO transcription factor, leading to cell cycle arrest and
apoptosis in pancreatic cancer. J Mol Signal. 5:102010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shankar S, Marsh L and Srivastava RK: EGCG
inhibits growth of human pancreatic tumors orthotopically implanted
in Balb C nude mice through modulation of FKHRL1/FOXO3a and
neuropilin. Mol Cell Biochem. 372:83–94. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Srivastava RK, Unterman TG and Shankar S:
FOXO transcription factors and VEGF neutralizing antibody enhance
antiangiogenic effects of resveratrol. Mol Cell Biochem.
337:201–212. 2010. View Article : Google Scholar : PubMed/NCBI
|
